Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma

NCT06940518 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Ivonescimab
Clear Cell Renal Carcinoma

Interventions

DRUG: Ivonescimab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]